These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18177462)

  • 1. The sign of the bias of unmeasured confounding.
    VanderWeele TJ
    Biometrics; 2008 Sep; 64(3):702-706. PubMed ID: 18177462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sign of the unmeasured confounding bias under various standard populations.
    Chiba Y
    Biom J; 2009 Aug; 51(4):670-6. PubMed ID: 19650054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal directed acyclic graphs and the direction of unmeasured confounding bias.
    VanderWeele TJ; Hernán MA; Robins JM
    Epidemiology; 2008 Sep; 19(5):720-8. PubMed ID: 18633331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
    Kasza J; Wolfe R; Schuster T
    Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
    Fewell Z; Davey Smith G; Sterne JA
    Am J Epidemiol; 2007 Sep; 166(6):646-55. PubMed ID: 17615092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
    Li Y; Lee Y; Port FK; Robinson BM
    Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
    Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
    Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A general approach to evaluating the bias of 2-stage instrumental variable estimators.
    Wan F; Small D; Mitra N
    Stat Med; 2018 May; 37(12):1997-2015. PubMed ID: 29572890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity analysis: distributional assumptions and confounding assumptions.
    Vanderweele TJ
    Biometrics; 2008 Jun; 64(2):645-9. PubMed ID: 18482060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of male osteoporosis and prostate cancer.
    Gilbert SM; McKiernan JM
    Curr Opin Urol; 2005 Jan; 15(1):23-7. PubMed ID: 15586025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses.
    Palmer TM; Thompson JR; Tobin MD; Sheehan NA; Burton PR
    Int J Epidemiol; 2008 Oct; 37(5):1161-8. PubMed ID: 18463132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
    Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
    BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy: further confirmation of known harms.
    Beebe-Dimmer JL; Freedland SJ
    BJU Int; 2013 May; 111(5):690-1. PubMed ID: 23418703
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity analysis for interactions under unmeasured confounding.
    Vanderweele TJ; Mukherjee B; Chen J
    Stat Med; 2012 Sep; 31(22):2552-64. PubMed ID: 21976358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
    Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity analysis for causal inference under unmeasured confounding and measurement error problems.
    Díaz I; van der Laan MJ
    Int J Biostat; 2013 Nov; 9(2):149-60. PubMed ID: 24246288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.